Vaxart Oral COVID-19 Vaccine Joins Trump’s “Warp Speed,” Ramps Up Manufacturing Capacity
3 "Strong Buy" Coronavirus Stocks With Massive Upside Potential
Gilead Sets Pricing For Remdesivir Vaccine At $2,340 Per Patient
Existing drugs can prevent SARS-CoV-2 from hijacking cells
Former FDA Chief Warns "Half The Population" Could Catch Coronavirus By Year End: Live Updates
Coronavirus Causes Weaponized 'Tentacles' To Sprout From Infected Cells, Directly Inject Virus Into New Ones
Molecular Partners hopes for COVID-19 rebound after eye drug failure
Vaxart Explodes 96%- And Rallies After-Hours- On Covid-19 Deal
3 Biotech Stocks Under $5 With 100%-Plus Upside Potential
Entos Pharmaceuticals announces selection of lead DNA vaccine candidates for COVID-19
3 Under-the-Radar Penny Stocks Gearing up for Gains
Top Analysts See 100%-Plus Upside Potential in These 3 Penny Stocks
Top Analysts Bet on These 3 Penny Stocks; See 100%-Plus Upside Potential
APT Doubles While Other Biotechs Take Off On Rising New Coronavirus Case Numbers
3 "Strong Buy" Penny Stocks With Triple-Digit Upside Potential
3 "Strong Buy" Stocks Under $5 With Triple-Digit Upside Potential
HyperPoint relaunches with new CEO and COVID-19 testing client
Lawmakers ask FDA to outline Covid-19 vaccine approval process
3 "Perfect 10" Stocks Under $10 With Big Upside Potential
Germany Reimposes COVID-19 Lockdown As Global Cases Top 9 Million: Live Updates
Covid-19 detection kits market will touch $8.5 billion by 2026
Apyx Spikes 45% In Pre-Market On Nod To Sell Helium Products In New Countries
Sanofi, Translate Bio Ramp Up Billion-Dollar mRNA Vaccine Collaboration
Gilead Aims To Produce More Than 2 Million Remdesivir Courses By Year-End
Evoke Pharma Pops 86% In Pre-Market On FDA Approval Of Gimoti Nasal Spray
Cipla launches COVID-19 drug remdesivir in India as disease takes hold
Poseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D
Moderna Leads the Pack With Its COVID-19 Vaccine, Says Top Analyst
Hours after blockbuster patent win, Mylan asks the FDA to speed up an OK to market a generic to Biogen’s Tecfidera
Boehringer Ingelheim nabs new US president and CEO; AstraZeneca vet hops aboard Novavax as CMO